Guidance

Nursing Guidance

• Patient Care Plan for a Skin Tunnelled Catheter Guideline V3.4
• Patient Care Plan for Care of Peripherally Inserted Central Catheter (PICC) Guideline V2.5
• Patient Care Plan For Care of Totally Implanted Venous Access Device (TIVAD) Guideline V3.4
• Patient's Central Venous Access Device (CVAD) Hand Held Records Form V7.1
• Standard PICC Dressing Sequence Guideline V1.2

Acute Oncology

• Immune Related Adverse Event Guideline - Arthralgia/Myalgia V1.1
• Immune Related Adverse Event Guideline - Cytokine Release Syndrome V1.0
• Immune Related Adverse Event Guideline - Diarrhoea V3.3
• Immune Related Adverse Event Guideline - Endocrinopathies - Adrenal Crisis V2.3
• Immune Related Adverse Event Guideline - Endocrinopathies - Hypophysitis V2.3
• Immune Related Adverse Event Guideline - Endocrinopathies - Thyroid Dysfunction V1.3
• Immune Related Adverse Event Guideline - General Management Advice V1.1
• Immune Related Adverse Event Guideline - Hepatoxicity V3.2
• Immune Related Adverse Event Guideline - Mucositis V1.0
• Immune Related Adverse Event Guideline - Myocarditis V1.2
• Immune Related Adverse Event Guideline - Neurological Toxicities V2.2
• Immune Related Adverse Event Guideline - Pneumonitis V3.1
• Immune Related Adverse Event Guideline - Renal Toxicities V2.2
• Immune Related Adverse Event Guideline - Skin Toxicities V2.2
• Uridine Triacetate for Patients with Early-Onset Severe Toxicities Following 5-Fluorouracil or Capecitabine Guideline V1.0

The Clatterbridge Cancer Centre NHS FT wishes to ensure your safety whilst undergoing cancer treatment with us. It is important to inform us about any medicines you are taking or have taken for your Cancer treatment.

If you have had Cancer treatment outside of the UK or privately before this episode we need to know about these treatments, this includes experimental, complimentary and non-standard medicines. It is important that we have an understanding of your complete medicines history to ensure your safety.

Immuno-Oncology Guidelines

• Steroid Tapering Guidance V4.0
• Subsequent Management Guidelines - Arthralgia V1.0
• Subsequent Management Guideline– Colitis V1.0
• Subsequent Management Guidelines - Dermatitis V1.0
• Subsequent Management Guideline– Hepatitis V1.0
• Subsequent Management Guidelines - Myocarditis V1.0
• Subsequent Management Guidelines - Nephritis V1.0
• Subsequent Management Guidelines - Pneumonitis V2.0

Home Treatment Protocols